Chemify Secures Gates Foundation Grant for Drug Discovery
Chemify, a pioneering deep tech chemical science company based in Glasgow, Scotland, UK, has recently achieved a significant milestone by securing a grant from the renowned Bill & Melinda Gates Foundation. This funding is earmarked for the discovery of innovative drug leads aimed at combating two of the world’s most persistent diseases: tuberculosis (TB) and malaria. With the application of their proprietary Chemputation technology and sophisticated workflow, Chemify aspires to revolutionize drug design and discovery processes, ultimately delivering promising drug candidates that can substantially improve the health and quality of life for patients across the globe.
Under the dynamic leadership of its CEO, Dr.
Lee Cronin, Chemify is at the forefront of combining advanced chemistry, robotics, and artificial intelligence to foster digital design and discovery of new molecules at an unprecedented scale. The innovative team's approach involves designing, synthesizing, and discovering chemical compounds with the aid of their state-of-the-art Chemputation technology, which serves as a seamless, automated digital chemical stack. This system harnesses the power of cheminformatics, robotics, and AI, effectively connecting the dots between digital design, planning, and the multiplexed synthesis of novel small molecules. Throughout this process, potential drug leads will be continually optimized with the support of Chemification-driven AI during each iterative development cycle.
The origin of Chemify is rooted in academic excellence, having been founded by the visionary Professor Lee Cronin. The company spun out from the Digital Chemistry Laboratory at the University of Glasgow with a mission to digitalize chemistry on a global scale for the betterment of humanity. This ambitious goal highlights Chemify's commitment to leveraging advanced technology to drive monumental changes in the pharmaceutical landscape, ultimately leading to effective treatments that can address pressing health challenges faced worldwide. With the backing of influential partners and foundation grants, Chemify is well-positioned to advance its initiatives and make significant contributions to the fields of chemistry and medicine.
They've invested in Chemify
Get to know these Biotech investors
Click here for a full list of 6,908+ startup investors in the UK